18539917

Source:http://linkedlifedata.com/resource/pubmed/id/18539917

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011860, umls-concept:C0017725, umls-concept:C1280500, umls-concept:C2003888
pubmed:issue	24
pubmed:dateCreated	2008-6-13
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00000620
pubmed:abstractText	Epidemiologic studies have shown a relationship between glycated hemoglobin levels and cardiovascular events in patients with type 2 diabetes. We investigated whether intensive therapy to target normal glycated hemoglobin levels would reduce cardiovascular events in patients with type 2 diabetes who had either established cardiovascular disease or additional cardiovascular risk factors.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/IAA-Y1-HC-1010, http://linkedlifedata.com/resource/pubmed/grant/IAA-Y1-HC-9035, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95178, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95179, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95180, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95181, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95182, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95183, http://linkedlifedata.com/resource/pubmed/grant/N01-HC-95184
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18539915, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18539918, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18539919, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18783183, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18832252, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18837144, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18837145, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-18957955, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19004118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19043027, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19101398, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19103831, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19192417, http://linkedlifedata.com/resource/pubmed/commentcorrection/18539917-19476576
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1533-4406
pubmed:author	pubmed-author:Action to Control Cardiovascular Risk in Diabetes Study Group, pubmed-author:BiggerJ ThomasJT, pubmed-author:BuseJohn BJB, pubmed-author:ByingtonRobert PRP, pubmed-author:CushmanWilliam CWC, pubmed-author:FriedewaldWilliam TWT, pubmed-author:GenuthSaulS, pubmed-author:GersteinHertzel CHC, pubmed-author:GoffDavid CDCJr, pubmed-author:GrimmRichard HRHJr, pubmed-author:Ismail-BeigiFaramarzF, pubmed-author:MillerMichael EME, pubmed-author:ProbstfieldJeffrey LJL, pubmed-author:Simons-MortonDenise GDG
pubmed:copyrightInfo	2008 Massachusetts Medical Society
pubmed:issnType	Electronic
pubmed:day	12
pubmed:volume	358
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2545-59
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18539917-Adult, pubmed-meshheading:18539917-Aged, pubmed-meshheading:18539917-Blood Glucose, pubmed-meshheading:18539917-Cardiovascular Diseases, pubmed-meshheading:18539917-Diabetes Mellitus, Type 2, pubmed-meshheading:18539917-Drug Therapy, Combination, pubmed-meshheading:18539917-Female, pubmed-meshheading:18539917-Follow-Up Studies, pubmed-meshheading:18539917-Hemoglobin A, Glycosylated, pubmed-meshheading:18539917-Humans, pubmed-meshheading:18539917-Hypertension, pubmed-meshheading:18539917-Hypoglycemia, pubmed-meshheading:18539917-Hypoglycemic Agents, pubmed-meshheading:18539917-Kaplan-Meier Estimate, pubmed-meshheading:18539917-Male, pubmed-meshheading:18539917-Middle Aged, pubmed-meshheading:18539917-Proportional Hazards Models, pubmed-meshheading:18539917-Treatment Failure
pubmed:year	2008
pubmed:articleTitle	Effects of intensive glucose lowering in type 2 diabetes.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural